查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1459776

生物製藥發酵系統市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Biopharmaceutical Fermentation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 254 Pages | 商品交期: 2-10個工作天內

價格

生物製藥發酵系統市場 - 報告範圍

TMR 關於全球生物製藥發酵系統市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球生物製藥發酵系統的收入2017- 2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球生物製藥發酵系統市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解生物製藥發酵系統市場。

市場概況
2022年市場價​​值 234 億美元
2031 年市場價值 526 億美元
CAGR 9.5%

該報告深入研究了全球生物製藥發酵系統市場的競爭格局。全球生物製藥發酵系統市場的主要參與者已經確定，並且每個參與者都根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球生物製藥發酵系統市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按產品，2017-2031
    • 上游產品
      • 發酵槽
      • 生物過程分析儀
      • 製程監控設備
      • 文化與媒體準備
      • 培養基以及緩衝劑和誘導劑
      • 其他上游產品
    • 下游產品
      • 過濾和分離系統
      • 色譜法
      • 耗材及配件
      • 其他下游產品
  • 市場吸引力分析：按產品

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 重組蛋白
    • 單株抗體
    • 抗生素
    • 益生菌
    • 其他
  • 市場吸引力分析：按應用

第 8 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 生物製藥公司
    • 合約製造組織
    • 合約研究組織
    • 學術研究機構
    • 食品工業
    • 其他
  • 市場吸引力分析：按最終用戶

第 9 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

第 10 章：北美市場分析與預測

第 11 章：歐洲市場分析與預測

第 12 章：亞太市場分析與預測

第 13 章：拉丁美洲市場分析與預測

第 14 章：中東和非洲市場分析與預測

第 15 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • GE Healthcare
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Sartorius Stedim Biotech
    • F. Hoffman-La Roche Ltd.
    • Eppendorf AG
    • Merck KGaA
    • Nova Biomedical
    • Lonza Group AG
    • BD
Product Code: TMRGL46989

Biopharmaceutical Fermentation Systems Market - Scope of Report

TMR's report on the global biopharmaceutical fermentation systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biopharmaceutical fermentation systems market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biopharmaceutical fermentation systems market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the biopharmaceutical fermentation systems market.

Market Snapshot
Market Value in 2022US$ 23.4 Bn
Market Value in 2031US$ 52.6 Bn
CAGR9.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biopharmaceutical fermentation systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biopharmaceutical fermentation systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biopharmaceutical fermentation systems market.

The report delves into the competitive landscape of the global biopharmaceutical fermentation systems market. Key players operating in the global biopharmaceutical fermentation systems market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biopharmaceutical fermentation systems market profiled in this report.

Key Questions Answered in Global biopharmaceutical fermentation systems Market Report:

  • What is the sales/revenue generated by biopharmaceutical fermentation systems across all regions during the forecast period?
  • What are the opportunities in the global biopharmaceutical fermentation systems market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Biopharmaceutical Fermentation Systems Market - Research Objectives and Research Approach

The comprehensive report on the global biopharmaceutical fermentation systems market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biopharmaceutical fermentation systems market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biopharmaceutical fermentation systems market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Biopharmaceutical Fermentation Systems Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution/Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Upstream Products
      • 6.3.1.1. Fermenters
      • 6.3.1.2. Bioprocess Analyzers
      • 6.3.1.3. Process Monitoring Devices
      • 6.3.1.4. Culture & Media Preparation
      • 6.3.1.5. Culture Media and Buffers & Inducers
      • 6.3.1.6. Other Upstream Products
    • 6.3.2. Downstream Products
      • 6.3.2.1. Filtration & Separation Systems
      • 6.3.2.2. Chromatography
      • 6.3.2.3. Consumables & Accessories
      • 6.3.2.4. Other Downstream Products
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Recombinant Proteins
    • 7.3.2. Monoclonal Antibodies
    • 7.3.3. Antibiotics
    • 7.3.4. Probiotics
    • 7.3.5. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Biopharmaceutical Companies
    • 8.3.2. Contract Manufacturing Organizations
    • 8.3.3. Contract Research Organizations
    • 8.3.4. Academic Research Institutes
    • 8.3.5. Food Industry
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Market Value Forecast, by Product, 2017-2031
    • 10.3.1. Upstream Products
      • 10.3.1.1. Fermenters
      • 10.3.1.2. Bioprocess Analyzers
      • 10.3.1.3. Process Monitoring Devices
      • 10.3.1.4. Culture & Media Preparation
      • 10.3.1.5. Culture Media and Buffers & Inducers
      • 10.3.1.6. Other Upstream Products
    • 10.3.2. Downstream Products
      • 10.3.2.1. Filtration & Separation Systems
      • 10.3.2.2. Chromatography
      • 10.3.2.3. Consumables & Accessories
      • 10.3.2.4. Other Downstream Products
  • 10.4. Market Value Forecast, by Application, 2017-2031
    • 10.4.1. Recombinant Proteins
    • 10.4.2. Monoclonal Antibodies
    • 10.4.3. Antibiotics
    • 10.4.4. Probiotics
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by End-user, 2017-2031
    • 10.5.1. Biopharmaceutical Companies
    • 10.5.2. Contract Manufacturing Organizations
    • 10.5.3. Contract Research Organizations
    • 10.5.4. Academic Research Institutes
    • 10.5.5. Food Industry
    • 10.5.6. Others
  • 10.6. Market Value Forecast, by Country, 2017-2031
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. Market Attractiveness Analysis
    • 10.7.1. By Product
    • 10.7.2. By Application
    • 10.7.3. By End-user
    • 10.7.4. By Country

11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 11.1. Introduction
  • 11.2. Key Findings
  • 11.3. Market Value Forecast, by Product, 2017-2031
    • 11.3.1. Upstream Products
      • 11.3.1.1. Fermenters
      • 11.3.1.2. Bioprocess Analyzers
      • 11.3.1.3. Process Monitoring Devices
      • 11.3.1.4. Culture & Media Preparation
      • 11.3.1.5. Culture Media and Buffers & Inducers
      • 11.3.1.6. Other Upstream Products
    • 11.3.2. Downstream Products
      • 11.3.2.1. Filtration & Separation Systems
      • 11.3.2.2. Chromatography
      • 11.3.2.3. Consumables & Accessories
      • 11.3.2.4. Other Downstream Products
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Recombinant Proteins
    • 11.4.2. Monoclonal Antibodies
    • 11.4.3. Antibiotics
    • 11.4.4. Probiotics
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Biopharmaceutical Companies
    • 11.5.2. Contract Manufacturing Organizations
    • 11.5.3. Contract Research Organizations
    • 11.5.4. Academic Research Institutes
    • 11.5.5. Food Industry
    • 11.5.6. Others
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Italy
    • 11.6.5. Spain
    • 11.6.6. Rest of Europe
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By End-user
    • 11.7.4. By Country/Sub-region

12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 12.1. Introduction
  • 12.2. Key Findings
  • 12.3. Market Value Forecast, by Product, 2017-2031
    • 12.3.1. Upstream Products
      • 12.3.1.1. Fermenters
      • 12.3.1.2. Bioprocess Analyzers
      • 12.3.1.3. Process Monitoring Devices
      • 12.3.1.4. Culture & Media Preparation
      • 12.3.1.5. Culture Media and Buffers & Inducers
      • 12.3.1.6. Other Upstream Products
    • 12.3.2. Downstream Products
      • 12.3.2.1. Filtration & Separation Systems
      • 12.3.2.2. Chromatography
      • 12.3.2.3. Consumables & Accessories
      • 12.3.2.4. Other Downstream Products
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Recombinant Proteins
    • 12.4.2. Monoclonal Antibodies
    • 12.4.3. Antibiotics
    • 12.4.4. Probiotics
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Biopharmaceutical Companies
    • 12.5.2. Contract Manufacturing Organizations
    • 12.5.3. Contract Research Organizations
    • 12.5.4. Academic Research Institutes
    • 12.5.5. Food Industry
    • 12.5.6. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By End-user
    • 12.7.4. By Country/Sub-region

13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 13.1. Introduction
  • 13.2. Key Findings
  • 13.3. Market Value Forecast, by Product, 2017-2031
    • 13.3.1. Upstream Products
      • 13.3.1.1. Fermenters
      • 13.3.1.2. Bioprocess Analyzers
      • 13.3.1.3. Process Monitoring Devices
      • 13.3.1.4. Culture & Media Preparation
      • 13.3.1.5. Culture Media and Buffers & Inducers
      • 13.3.1.6. Other Upstream Products
    • 13.3.2. Downstream Products
      • 13.3.2.1. Filtration & Separation Systems
      • 13.3.2.2. Chromatography
      • 13.3.2.3. Consumables & Accessories
      • 13.3.2.4. Other Downstream Products
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Recombinant Proteins
    • 13.4.2. Monoclonal Antibodies
    • 13.4.3. Antibiotics
    • 13.4.4. Probiotics
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Biopharmaceutical Companies
    • 13.5.2. Contract Manufacturing Organizations
    • 13.5.3. Contract Research Organizations
    • 13.5.4. Academic Research Institutes
    • 13.5.5. Food Industry
    • 13.5.6. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By End-user
    • 13.7.4. By Country/Sub-region

14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast

  • 14.1. Introduction
  • 14.2. Key Findings
  • 14.3. Market Value Forecast, by Product, 2017-2031
    • 14.3.1. Upstream Products
      • 14.3.1.1. Fermenters
      • 14.3.1.2. Bioprocess Analyzers
      • 14.3.1.3. Process Monitoring Devices
      • 14.3.1.4. Culture & Media Preparation
      • 14.3.1.5. Culture Media and Buffers & Inducers
      • 14.3.1.6. Other Upstream Products
    • 14.3.2. Downstream Products
      • 14.3.2.1. Filtration & Separation Systems
      • 14.3.2.2. Chromatography
      • 14.3.2.3. Consumables & Accessories
      • 14.3.2.4. Other Downstream Products
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Recombinant Proteins
    • 14.4.2. Monoclonal Antibodies
    • 14.4.3. Antibiotics
    • 14.4.4. Probiotics
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Biopharmaceutical Companies
    • 14.5.2. Contract Manufacturing Organizations
    • 14.5.3. Contract Research Organizations
    • 14.5.4. Academic Research Institutes
    • 14.5.5. Food Industry
    • 14.5.6. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. GCC Countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By End-user
    • 14.7.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. GE Healthcare
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Thermo Fisher Scientific Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Danaher Corporation
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Sartorius Stedim Biotech
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. F. Hoffman-La Roche Ltd.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Eppendorf AG
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Merck KGaA
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Nova Biomedical
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Lonza Group AG
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. BD
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Financial Overview
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 05: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 12: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 13: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 14: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 15: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 17: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 18: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 19: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2017-2031
  • Table 23: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 24: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution (%), by Region, 2022-2031
  • Figure 02: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Product, 2022
  • Figure 03: Global Biopharmaceutical Fermentation Systems Market Value Share, by Product, 2022
  • Figure 04: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by Application, 2022
  • Figure 05: Global Biopharmaceutical Fermentation Systems Market Value Share, by Application, 2022
  • Figure 06: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn), by End-user, 2022
  • Figure 07: Global Biopharmaceutical Fermentation Systems Market Value Share, by End-user, 2022
  • Figure 08: Global Biopharmaceutical Fermentation Systems Market Value Share, by Region, 2022
  • Figure 09: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 11: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 13: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 14: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 15: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 16: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2022-2031
  • Figure 17: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 18: North America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 19: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 20: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2022-2031
  • Figure 21: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 22: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 23: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 24: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 25: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 26: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Europe Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 28: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 30: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 31: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 32: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 33: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 34: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 35: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 36: Asia Pacific Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 37: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 38: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 40: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 41: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 42: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 43: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 44: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 45: Latin America Biopharmaceutical Fermentation Systems Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 46: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 47: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 48: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 49: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 50: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 52: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 53: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 54: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 55: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 56: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 57: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2022-2031
  • Figure 58: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2022-2031
  • Figure 59: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2022-2031
  • Figure 60: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 61: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 62: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2023-2031